ArticleBMJ open respiratory research2022

CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial.

Zoran Popmihajlov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.